![Michael Bumby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bumby
Directeur Financier/CFO chez
XORTX THERAPEUTICS INC.
Fortune : 26 282 $ au 31/05/2026
Profil
Michael Bumby is the founder of Bluenose & Co., founded in 2013.
Dr. Bumby is currently Director at reBOOT Canada since 2013, Director at MediPharm Labs Corp.
starting 2026, Chief Financial Officer at Trimel Biopharma, Inc. since 2015, and Chief Financial Officer at XORTX Therapeutics, Inc. since 2024.
Former positions include Director-Finance & Investment Banking at Eli Lilly & Co. from 2000 to 2011, Independent Director at MediPharm Labs Corp.
from 2023 to 2025, Chief Financial Officer at Merus Labs, Inc. from 2016 to 2017, Chief Financial Officer & Secretary at VIVO Cannabis, Inc. from 2021 to 2023, Chief Financial Officer & Head-Investor Relations at Antibe Therapeutics, Inc. from 2013 to 2015, Chief Financial Officer at Acerus Pharmaceuticals Corp.
from 2015 to 2016, Chief Financial Officer & Investor Contact at Merus Labs International, Inc., and Chief Financial Officer at Antibe Holdings, Inc. from 2012 to 2015.
Education includes a doctorate from the University of Guelph and an MBA from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDIPHARM LABS CORP. 0,11% | 01/01/2026 | 461 092 ( 0,11% ) | 26 282 $ | 31/05/2026 |
| 19/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Michael Bumby
| Sociétés | Poste | Début |
|---|---|---|
| XORTX THERAPEUTICS INC. | Directeur Financier/CFO | 19/12/2024 |
| MEDIPHARM LABS CORP. | Directeur/Membre du Conseil | 01/01/2026 |
Trimel Biopharma, Inc.
 Trimel Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Directeur Financier/CFO | 03/08/2015 |
reBOOT Canada | Directeur/Membre du Conseil | 01/09/2013 |
Anciens postes connus de Michael Bumby
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIPHARM LABS CORP. | Directeur/Membre du Conseil | 17/06/2025 |
| VIVO CANNABIS INC. | Directeur Financier/CFO | 01/04/2023 |
Merus Labs, Inc.
 Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Financier/CFO | 01/01/2017 |
| ACERUS PHARMACEUTICALS CORPORATION | Directeur Financier/CFO | 01/06/2016 |
| ANTIBE THERAPEUTICS INC. | Directeur Financier/CFO | 01/08/2015 |
Formation de Michael Bumby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus Labs, Inc.
Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Antibe Therapeutics, Inc.
 Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Merus Labs International, Inc.
 Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Antibe Holdings, Inc.
 Antibe Holdings, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Trimel Biopharma, Inc.
Trimel Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
reBOOT Canada | |
Bluenose & Co. | |
VIVO Cannabis, Inc.
 VIVO Cannabis, Inc. Agricultural Commodities/MillingProcess Industries Produces and sells medical cannabis products | Process Industries |
XORTX Therapeutics, Inc.
 XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
MediPharm Labs Corp.
 MediPharm Labs Corp. Agricultural Commodities/MillingProcess Industries Engages in the pharmaceutical grade production of cannabis oil products | Process Industries |
